| Título: | Margin Status Influence on the Outcome of Patients Treated with Breast Conserving Surgery |
| Autores: |
Akbari, ME Akbari, M Zirakzadeh, H Nafisi, N Heidari, A Hosseinizadegan Shirazi, F |
| Fecha: | 2012-02-02 |
| Publicador: | Shahid Beheshti University of Medical Sciences |
| Fuente: |
Ver documento |
| Tipo: |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| Tema: | No aplica |
| Descripción: | Background: Breast conserving surgery (BCS) followed by local radiotherapy is the standard treatment for early stage of breast cancer. Margin status may have an important impact on local recurrence and overall survival of patients treated with BCS, but this has not been defined adequately. In this study, we investigated the relationship between microscopic margins and outcome of BCS. Methods: Three hundred eighty four patients treated with BCS between 1999 and2010 were included in our study. All surgeries were performed by a single surgical team. Margins were defined as close if surgical margins were less than 2 mm, as free if surgical margins were more than 2 mm and as positive if malignant cells were present in one of the tissue edges. Demographic, clinical, and pathological factors as well as biological markers, recurrence, and survival rates were compared between the close and the free margins groups. Results: The mean age of patients at the time of diagnosis was 54.2 years. There were 34 (9%) recurrence cases and overall survival was 128.7 months and ten years survival rate was 81%. There was no significant difference between the close and the free margins groups in terms of demographic parameters, tumor characteristics, biological factors (estrogen and progesterone receptor status) and lymphovascular invasion. Also recurrence rate did not differ significantly between these two groups. Conclusion: Our study indicates that there is no significant difference between the patients with close and the free margins in terms of treatment results. There is no clear consensus in the surgeons’ community over the definition of acceptable margin width in BCS, so additional studies are required to find the right answer.Key words: Breast neoplasm; Breast-conserving surgery; Recurrence; Margin References1. Akbari M E , Abachizadeh K , Khayamzadeh M,Tabatabaee M , Esnaashari FG , Motlagh A ,et al. Cancerin Iran. Qom: Darolfekr, In Persian; 2008.2. Baselga J, Mendelsohn J. The epidermal growth factor receptor as a target for therapy in breastcarcinoma. Breast Cancer Res Treat. 1994 Jan;29(1):127-38.3. Naghavi M. Iranian annual of national death registration report. Ministry of Health and Medical Education, 2005.4. Ministry of Health and Medical Education, Healthdeputy. National Burden of Disease and Injury in I.R.Iran,2006.5. Jordan VC. SERMs: meeting the promise of multifunctional medicines. J Natl Cancer Inst. 2007 Mar 7;99(5):350-6.6. Fisher B, Anderson S, Bryant J, Margolese RG,Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002Oct 17; 347(16):1233-41.7. Blichert-Toft M, Nielsen M, Düring M, Møller S, RankF, Overgaard M, et al. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol. 2008;47(4):672-81.8. Akbari ME, Khayamzadeh M, Khoshnevis SJ, Nafisi N, Akbari A. Five and ten years survival in breast cancer patient's mastectomies vs. breast conserving surgeries personal experience. Iran J Cancer Prev. 2008; 1(2):53-6.9. Early Breast Cancer Trialists' Collaborative Group. Radiotherapy for early breast cancer. Cochrane Database Syst Rev. 2002 ;( 2):CD003647.10. Clarke M, Collins R, Darby S, Davies C, ElphinstoneP, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005 Dec 17;366(9503):2087-106.11. Freedman G, Fowble B, Hanlon A, Nicolaou N, FeinD, Hoffman J, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1005-15.12. Kunos C, Latson L, Overmoyer B, Silverman P, ShenkR, Kinsella T, et al. Breast conservation surgeryachieving>or=2 mm tumor-free margins results in decreased local-regional recurrence rates. Breast J. 2006Jan-Feb; 12(1):28-36.13. Vargas C, Kestin L, Go N, Krauss D, Chen P,Goldstein N, et al. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast- conserving therapy or mastectomy. Int J Radiat Oncol Biol Phys. 2005 Dec 1; 63(5):1514-21.14. Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg. 2002 Nov; 184(5):383-93.15. Olson TP, Harter J, Muñoz A, Mahvi DM, Breslin T. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence. Ann Surg Oncol.2007 Oct; 14(10):2953-60.16. Noguchi M, Minami M, Earashi M, Taniya T,Miyazaki I, Mizukami Y, Pathologic Assessment of Surgical Margins on Frozen and Permanent Sections in Breast Conserving Surgery. Breast Cancer. 1995 Apr 30;2(1):27-33.17. Jobsen JJ, Van Der Palen J, Ong F, Meerwaldt JH. Differences in outcome for positive margins in a large cohort of breast cancer patients treated with breast- conserving therapy. Acta Oncol. 2007; 46(2):172-80.18. Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JC, Jager JJ, et al. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer. 2003 May; 39(7):932-44.19. Dillon MF, Hill AD, Quinn CM, McDermott EW, O'Higgins N. A pathologic assessment of adequate margin status in breast-conserving therapy. Ann Surg Oncol. 2006Mar; 13(3):333-9.20. Akbari ME, Mozaffar M, Heidari A, Zirakzadeh H, Akbari A, Akbari M, Hosseinizadegan Shirazi F. Recurrence and Survival Effect in Breast Conserving Surgery: What are the Predictive and/or Prognostic Factors? 2011 spring; 4(2): 49-54.21. Kurtz JM, Amalric R, Brandone H, Ayme Y,Jacquemier J, Pietra JC, et al. Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer. 1989 May 15;63(10):1912-7.22. Silverstein MJ, Barth A, Poller DN, Gierson ED, Colburn WJ, Waisman JR, et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer.1995; 31A (9):1425-7.23. Solin LJ, Recht A, Fourquet A, Kurtz J, Kuske R,McNeese M, et al. Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast. Cancer.1991 Dec 1; 68(11):2337-44.24. Dunne C, Burke JP, Morrow M, Kell MR. Effect ofmargin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol. 2009 Apr 1; 27(10):1615-20.25. Houssami N, Macaskill P, Marinovich ML, Dixon JM, Irwig L, Brennan ME, et al. Meta-analysis of the impact of surgical margins on local recurrence in women with early- stage invasive breast cancer treated with breast- conserving therapy. Eur J Cancer. 2010 Dec;46(18):3219-32.26. Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989 Mar 30; 320(13):822-8.27. van Dongen JA, Bartelink H, Fentiman IS, Lerut T,Mignolet F, Olthuis G, et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and I1 breast cancer. Eur J Cancer. 1992; 28A (4-5):801-5.28. Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg. 2005 Apr; 241(4):629-39.29. Hardy K, Fradette K, Gheorghe R, Lucman L, Latosinsky S. The impact of margin status on localrecurrence following breast conserving therapy for invasive carcinoma in Manitoba. J Surg Oncol. 2008 Nov1; 98(6):399-402.30. Zavagno G, Goldin E, Mencarelli R, Capitanio G,Del Bianco P, Marconato R, et al. Role of resection margins in patients treated with breast conservation surgery. Cancer. 2008 May 1; 112(9):1923-31.31. Luini A, Rososchansky J, Gatti G, Zurrida S, Caldarella P, Viale G, et al. The surgical margin statusafter breast-conserving surgery: discussion of an open issue. Breast Cancer Res Treat. 2009 Jan; 113(2):397-402.32. Park CC, Mitsumori M, Nixon A, Recht A, Connolly J,Gelman R, et al. Outcome at 8 years after breast- conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000 Apr;18(8):1668-75.33. Landis SH, Murray T, Bolden S, Wingo PA. Cancerstatistics, 1998. CA Cancer J Clin. 1998 Jan-Feb; 48(1):6-29.34. Nomura K, Sobue T, Nakatani H, Maehara H.Cancer statistics in Japan 2005.Tokyo-Japan foundation for promotion cancer research, 2005. |
| Idioma: | Inglés |
1 Health and Education - 2 por Akbari, Mohammad Esmaeil | 6 Effectiveness of Mindfulness-Based Cognitive Therapy on Reduction of Depression and Anxiety Symptoms in Mothers of Children With Cancer por Mehranfar, Mojtaba; Dept. of Counselling, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran,Younesi, Jalal; Dept. of Counselling, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran,Banihashem, Abdollah; Dept. of Internal Medicine and Paediatrics, University of
Medical Sciences, Mashhad, Iran |
2 The Study of DNA Methylation of bax Gene Promoter in Breast and Colorectal Carcinoma Cell Lines por Alipour, Mohsen; Dept. of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran,Zargar, Seyed Jalal; Dept. of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran,Safarian, Shahrokh; Dept. of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran,Fouladdel, Shamile; Dept. of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran,Azizi, Ebrahim; Dept. of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Biotechnology Research Center, Tehran University of Medical Sciences, Tehran, Iran,Jafargholizadeh, Naser; Dept. of Cell & Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran | 7 Prevention and Management of Mucositis in Patients With Cancer: a Review Article por [wlia, ّatemeh; Dept. of Oral Medicine, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, Iran,«azemeini, ُeidkazem; Burn hospital, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, Iran,gholami, neda; Dept. of Oral Medicine, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, Iran |
3 Cancer Prevention; Cancer Risk Management por Akbari, Mohammad Esmaeil | 8 Psychosocial Care for Breast Cancer: Physicians' Perspective por Kaviani, Ahmad; Department of surgery, Tehran University of Medical Sciences, Tehran, Iran,Mehrdad, N; Iranian Center for Breast Cancer (ICBC), Academic Center for Education, Culture and Research (ACECR), Tehran, Iran,Yunesian, M; school of Public Health , Environmental Research Center, Tehran University of Medical Sciences, Tehran, Iran,Shakiba, B; Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran,Ebrahimi, M; Iranian Center for Breast Cancer (ICBC), Academic Center for Education, Culture and Research (ACECR), Tehran, Iran,Majidzadeh, K; Iranian Center for Breast Cancer (ICBC), Academic Center for Education, Culture and Research (ACECR), Tehran, Iran,Akbari, ME; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran |
4 Euthanasia in Cancer Patients, Islamic Point of View por Mousavi, SM; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran,Akbari, A; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran,Akbari, ME; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran,Najd Sepas, H; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran | 9 Cell Survival Entropy and Cellular Resistance Activation Dose: Effect of Calprotectin on Gastric Adenocarcinoma Cell Line por Rezaei-Tavirani, Mostafa,Rahmati-Roodsari, Mohammad,Mirzaie, Mehdi,Amini Geram, Pooneh,Sobhi, Sara |
5 Evaluation of Prognostic Factors In Patients with Metastatic Breast Cancer por Saeidi Saedi, H,Seilanian Toosi, M,Mirsadraei, M,Roodbari, S | 10 Antiphospholipid Antibodies in Neoplastic Patients por Mortazavizadeh, MR,Sadeghmanesh, R |